Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20692391 | 1.00 | NLRP3 (0.41) | NLRP3GAACA1CA2CA12 | |
| SCHEMBL20692128 | 0.85 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL25034217 | 0.85 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL20692259 | 0.85 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL30243763 | 0.82 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL30243600 | 0.82 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL21893716 | 0.82 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL20692231 | 0.82 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL30263807 | 0.82 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL26010293 | 0.82 | NLRP3 (0.40) | NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102576-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |
| WO-2019023147-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | IFM Tre, Inc. (US) | 2019-01-31 | — | — | WO | disclosed |